1,1-dichloroethene increases expression ISO RGD:62097 6480464 vinylidene chloride results in increased expression of FGF7 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FGF7 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:69203 6480464 Estradiol results in increased expression of FGF7 mRNA, Estradiol results in increased expression of FGF7 protein CTD PMID:14999240 , PMID:21098263 17beta-estradiol increases expression ISO RGD:62097 6480464 Estradiol results in increased expression of FGF7 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62097 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:62097 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62097 6480464 Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA] CTD PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62097 6480464 Tetrachlorodibenzodioxin results in increased expression of FGF7 mRNA CTD PMID:15034205 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:69203 6480464 Triiodothyronine results in decreased expression of FGF7 mRNA CTD PMID:15507505 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:62097 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA more ... CTD PMID:16054899 3-methylcholanthrene multiple interactions ISO RGD:62097 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF7 mRNA CTD PMID:23519560 5-azacytidine decreases expression ISO RGD:69203 6480464 Azacitidine results in decreased expression of FGF7 mRNA CTD PMID:20823114 5-fluorouracil decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Fluorouracil, FGF7 results in decreased susceptibility to Fluorouracil CTD PMID:18575591 5-fluorouracil multiple interactions ISO RGD:69203 6480464 FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil], FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] CTD PMID:18575591 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FGF7 mRNA CTD PMID:28959563 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 aldehydo-D-glucosamine multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 aldehydo-D-glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 all-trans-retinoic acid multiple interactions ISO RGD:69203 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of CD68 mRNA more ... CTD PMID:35267148 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FGF7 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69203 6480464 pyrazolanthrone inhibits the reaction [FGF7 protein results in increased expression of FAS protein] more ... CTD PMID:15677771 , PMID:16162944 antirheumatic drug increases expression ISO RGD:69203 6480464 Antirheumatic Agents results in increased expression of FGF7 mRNA CTD PMID:24449571 ANTU increases expression EXP 6480464 alpha-naphthyl thiourea results in increased expression of FGF7 mRNA CTD PMID:10755703 arabinoxylan increases expression ISO RGD:69203 6480464 arabinoxylan results in increased expression of FGF7 mRNA CTD PMID:15678371 Aroclor 1254 increases expression ISO RGD:62097 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of FGF7 mRNA CTD PMID:23650126 arotinoid acid multiple interactions ISO RGD:69203 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane decreases expression ISO RGD:62097 6480464 Arsenic results in decreased expression of FGF7 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:62097 6480464 Arsenic results in decreased expression of FGF7 mRNA CTD PMID:19654921 arsenous acid decreases expression ISO RGD:69203 6480464 Arsenic Trioxide results in decreased expression of FGF7 mRNA CTD PMID:20458559 azathioprine increases expression ISO RGD:69203 6480464 Azathioprine results in increased expression of FGF7 mRNA CTD PMID:19192274 benzo[a]pyrene decreases expression ISO RGD:62097 6480464 Benzo(a)pyrene results in decreased expression of FGF7 mRNA CTD PMID:15034205 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 beta-D-glucosamine multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 bis(2-chloroethyl) sulfide decreases expression ISO RGD:62097 6480464 Mustard Gas results in decreased expression of FGF7 mRNA CTD PMID:15674843 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:69203 6480464 TNF protein affects the reaction [Mustard Gas affects the expression of FGF7 mRNA] CTD PMID:16173061 bisphenol A increases expression ISO RGD:62097 6480464 bisphenol A results in increased expression of FGF7 mRNA CTD PMID:27022677 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGF7 mRNA CTD PMID:25181051 bleomycin A2 increases expression ISO RGD:62097 6480464 Bleomycin results in increased expression of FGF7 protein CTD PMID:30825431 bleomycin A2 multiple interactions ISO RGD:62097 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF7 protein], lenabasum inhibits the reaction [Bleomycin results in increased expression of FGF7 protein] CTD PMID:30825431 boric acid increases expression ISO RGD:69203 6480464 boric acid results in increased expression of FGF7 protein CTD PMID:27206737 cadmium dichloride multiple interactions ISO RGD:69203 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein], Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein CTD PMID:26138014 cannabidiol increases expression ISO RGD:69203 6480464 Cannabidiol results in increased expression of FGF7 mRNA CTD PMID:27918106 cannabidiol multiple interactions ISO RGD:69203 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of FGF7 mRNA] CTD PMID:31250491 cannabidiol multiple interactions ISO RGD:62097 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF7 protein] CTD PMID:30825431 carbon nanotube decreases expression ISO RGD:62097 6480464 Nanotubes, Carbon results in decreased expression of FGF7 mRNA CTD PMID:25554681 CHIR 99021 multiple interactions ISO RGD:69203 6480464 [4-(2-(5 more ... CTD PMID:34480604 , PMID:35267148 cholesterol multiple interactions ISO RGD:69203 6480464 Cholesterol inhibits the reaction [FGF7 protein results in increased expression of FAS mRNA], Cholesterol inhibits the reaction [FGF7 protein results in increased expression of SCD mRNA] CTD PMID:16162944 cholesterol multiple interactions EXP 6480464 [1, 2-dioleoyloxy-3-(trimethylammonium)propane co-treated with Cholesterol] results in increased expression of FGF7 protein CTD PMID:16034455 cisplatin increases expression ISO RGD:62097 6480464 Cisplatin results in increased expression of FGF7 mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:69203 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of FGF7 mRNA CTD PMID:20705681 cortisol multiple interactions ISO RGD:69203 6480464 [4-(2-(5 more ... CTD PMID:34480604 coumarin increases phosphorylation ISO RGD:69203 6480464 coumarin results in increased phosphorylation of FGF7 protein CTD PMID:35688186 cyclosporin A decreases expression ISO RGD:69203 6480464 Cyclosporine results in decreased expression of FGF7 mRNA, Cyclosporine results in decreased expression of FGF7 protein CTD PMID:15250830 cyclosporin A increases expression ISO RGD:69203 6480464 Cyclosporine results in increased expression of FGF7 mRNA, Cyclosporine results in increased expression of FGF7 protein CTD PMID:15250830 D-glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 dermatan sulfate increases activity ISO RGD:62097 6480464 Dermatan Sulfate analog results in increased activity of FGF7 protein CTD PMID:15563459 dexamethasone multiple interactions ISO RGD:62097 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA more ... CTD PMID:16054899 diarsenic trioxide decreases expression ISO RGD:69203 6480464 Arsenic Trioxide results in decreased expression of FGF7 mRNA CTD PMID:20458559 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FGF7 mRNA CTD PMID:12632370 fluoranthene multiple interactions ISO RGD:62097 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 geldanamycin multiple interactions ISO RGD:69203 6480464 geldanamycin inhibits the reaction [ammonium trichloro(dioxoethylene-O, O'-)tellurate results in increased expression of FGF7 protein] CTD PMID:14656992 geldanamycin multiple interactions ISO RGD:62097 6480464 geldanamycin inhibits the reaction [ammonium trichloro(dioxoethylene-O, O'-)tellurate results in increased expression of FGF7 protein] CTD PMID:14656992 glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 graphite affects expression EXP 6480464 Graphite affects the expression of FGF7 mRNA CTD PMID:29933104 heparan sulfate affects binding ISO RGD:69203 6480464 Heparitin Sulfate binds to FGF7 protein CTD PMID:15769253 heparin affects binding EXP 6480464 [Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein CTD PMID:10860838 hyaluronic acid increases chemical synthesis EXP 6480464 FGF7 protein results in increased chemical synthesis of Hyaluronic Acid CTD PMID:14506240 hydrogen peroxide decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:16123449 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [FGF7 protein results in increased secretion of Dinoprostone] CTD PMID:16169897 L-ascorbic acid multiple interactions ISO RGD:69203 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:69203 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA CTD PMID:34480604 lead(0) affects expression ISO RGD:69203 6480464 Lead affects the expression of FGF7 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:69203 6480464 Lead affects the expression of FGF7 mRNA CTD PMID:28903495 lipopolysaccharide decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Lipopolysaccharides CTD PMID:14962112 lipopolysaccharide multiple interactions ISO RGD:69203 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of FGF7 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:62097 6480464 Lipopolysaccharides results in decreased expression of FGF7 mRNA CTD PMID:12057914 lipopolysaccharide increases expression ISO RGD:69203 6480464 Lipopolysaccharides results in increased expression of FGF7 mRNA, Lipopolysaccharides results in increased expression of FGF7 protein CTD PMID:11842940 LY294002 multiple interactions ISO RGD:69203 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[FGF7 protein results in increased phosphorylation of AKT1 protein] which results in increased expression of ESR1 protein] more ... CTD PMID:16162944 , PMID:19661335 medroxyprogesterone acetate decreases expression ISO RGD:69203 6480464 Medroxyprogesterone Acetate results in decreased expression of FGF7 mRNA CTD PMID:20843944 methotrexate increases expression ISO RGD:69203 6480464 Methotrexate results in increased expression of FGF7 mRNA CTD PMID:19192274 N-acetyl-L-cysteine multiple interactions ISO RGD:69203 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein] CTD PMID:26138014 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FGF7 mRNA CTD PMID:20360939 naphthalene multiple interactions ISO RGD:69203 6480464 [FGF7 protein modified form results in decreased expression of CYP2F2 mRNA] which results in decreased susceptibility to naphthalene CTD PMID:18385170 nickel atom decreases expression ISO RGD:62097 6480464 Nickel results in decreased expression of FGF7 mRNA CTD PMID:18922574 nifedipine increases secretion ISO RGD:69203 6480464 Nifedipine results in increased secretion of FGF7 protein CTD PMID:11023675 nifedipine increases expression ISO RGD:69203 6480464 Nifedipine results in increased expression of FGF7 mRNA CTD PMID:11023675 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FGF7 mRNA CTD PMID:12861530 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGF7 mRNA CTD PMID:25729387 paclitaxel multiple interactions ISO RGD:69203 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of FGF7 mRNA CTD PMID:20705681 PCB138 multiple interactions ISO RGD:62097 6480464 [2 more ... CTD PMID:25510870 pentanal decreases expression ISO RGD:69203 6480464 pentanal results in decreased expression of FGF7 mRNA CTD PMID:26079696 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FGF7 mRNA CTD PMID:20360939 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:62097 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF7 mRNA CTD PMID:23519560 pioglitazone multiple interactions ISO RGD:62097 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FGF7 mRNA CTD PMID:27935865 prostaglandin E2 increases secretion EXP 6480464 FGF7 protein results in increased secretion of Dinoprostone CTD PMID:16169897 prostaglandin E2 multiple interactions EXP 6480464 Indomethacin inhibits the reaction [FGF7 protein results in increased secretion of Dinoprostone] CTD PMID:16169897 quercetin increases expression ISO RGD:69203 6480464 Quercetin results in increased expression of FGF7 mRNA CTD PMID:15309432 resveratrol decreases expression ISO RGD:62097 6480464 resveratrol results in decreased expression of FGF7 mRNA CTD PMID:23525482 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:69203 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of FGF7 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69203 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of FGF7 mRNA CTD PMID:35811015 SB 203580 multiple interactions ISO RGD:62097 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:69203 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of FGF7 mRNA CTD PMID:34480604 shikimic acid increases expression ISO RGD:62097 6480464 Shikimic Acid results in increased expression of FGF7 mRNA CTD PMID:15265014 sirolimus multiple interactions ISO RGD:69203 6480464 Sirolimus inhibits the reaction [TP73 protein results in increased expression of FGF7 mRNA] CTD PMID:21245298 sodium atom increases transport ISO RGD:62097 6480464 FGF7 protein results in increased transport of Sodium CTD PMID:12757114 sodium aurothiomalate increases expression ISO RGD:69203 6480464 Gold Sodium Thiomalate results in increased expression of FGF7 mRNA CTD PMID:19192274 sunitinib decreases expression ISO RGD:69203 6480464 Sunitinib results in decreased expression of FGF7 mRNA CTD PMID:31533062 suramin affects localization ISO RGD:69203 6480464 Suramin affects the localization of FGF7 protein CTD PMID:15733146 suramin multiple interactions ISO RGD:69203 6480464 Suramin inhibits the reaction [FGF7 protein binds to FGFR2 protein] CTD PMID:15733146 tamoxifen decreases response to substance ISO RGD:69203 6480464 FGF7 results in decreased susceptibility to Tamoxifen CTD PMID:18575591 tamoxifen multiple interactions ISO RGD:69203 6480464 FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Tamoxifen] CTD PMID:18575591 tetrachloromethane increases expression ISO RGD:62097 6480464 Carbon Tetrachloride results in increased expression of FGF7 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FGF7 mRNA CTD PMID:17692400 tetraphene increases expression ISO RGD:62097 6480464 benz(a)anthracene results in increased expression of FGF7 mRNA CTD PMID:26377693 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FGF7 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:69203 6480464 titanium dioxide results in decreased expression of FGF7 mRNA CTD PMID:34973136 topotecan increases expression EXP 6480464 Topotecan results in increased expression of FGF7 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGF7 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:62097 6480464 Trichloroethylene results in increased expression of FGF7 mRNA CTD PMID:15363585 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FGF7 mRNA CTD PMID:33387578 trimellitic anhydride decreases expression ISO RGD:62097 6480464 trimellitic anhydride results in decreased expression of FGF7 mRNA CTD PMID:19042947 valproic acid decreases methylation ISO RGD:69203 6480464 Valproic Acid results in decreased methylation of FGF7 gene CTD PMID:29154799 wortmannin multiple interactions ISO RGD:69203 6480464 wortmannin inhibits the reaction [FGF7 protein results in increased expression of PLAC1 mRNA] CTD PMID:15803460 XAV939 multiple interactions ISO RGD:69203 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA CTD PMID:34480604
